Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
Latest Information Update: 18 May 2022
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms STIFLE-RISK
- 02 May 2022 Planned initiation date changed from 1 Feb 2022 to 1 Jul 2022.
- 02 May 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 20 Jul 2020 New trial record